DSC
BLFS icon

Duncker Streett & Co’s BioLife Solutions BLFS Stock Holding History

Duncker Streett & Co’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8K Buy
+170
New +$3.97K ﹤0.01% 450

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Duncker Streett & Co's BLFS Position: Q2 2026 in Review

Duncker Streett & Co opened a new position in BioLife Solutions (BLFS) in Q2 2026: 170 shares worth $4.8K. The stake represents ﹤0.01% of the portfolio and ranks #450 among its holdings.

216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Duncker Streett & Co held 170 shares of BioLife Solutions worth $4.8K as of Q2 2026.
  • BioLife Solutions was a new Duncker Streett & Co position in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of Duncker Streett & Co's portfolio in Q2 2026, its #450 holding.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.